Release Date: 23/04/20 08:24 Summary: Appendix 4C - Quarter ended 31 March 2020 Price Sensitive: Yes Download Document 304.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%